Clinical Scorecard: 1 in 4 US Army men may screen low for testosterone
At a Glance
Category
Detail
Condition
Low morning total testosterone concentrations in active-duty US Army men
Key Mechanisms
Age and BMI were associated with higher odds of testosterone concentrations below the study thresholds; illness, obesity, and physical stress can influence testosterone concentrations.
Target Population
Active-duty US Army men; the analysis included 479 participants with fasting morning testosterone measurements.
Care Setting
Military health screening and clinical evaluation; the study assessed prevalence estimates, not diagnosis of hypogonadism.
Key Highlights
An estimated 25.7% had morning total testosterone below 300 ng/dL; 14.7% were below 264 ng/dL.
The weighted mean morning total testosterone concentration was 405 ng/dL.
Low concentrations were more common among men aged 30 years or older than among younger men at both thresholds.
Each 5-unit increase in BMI was associated with 90% higher odds of concentrations below 300 ng/dL and 82% higher odds below 264 ng/dL.
The authors cautioned that screening estimates should not be interpreted as the prevalence of hypogonadism.
Guideline-Based Recommendations
Diagnosis
Current clinical guidelines recommend testosterone testing only for men with compatible signs or symptoms.
Interpretation should account for factors that can influence testosterone concentrations, including obesity, illness, and physical stress.
Management
Low morning testosterone concentrations require confirmation with repeat testing because of intraindividual and diurnal variation.
Monitoring & Follow-up
The article reports a new military policy requiring annual testosterone screening for active-duty and reserve personnel aged 30 years or older.
Risks
A single measurement may misclassify testosterone status, particularly near clinical thresholds.
The cross-sectional design does not establish causality, and the study estimates do not represent the prevalence of hypogonadism.
Patient & Prescribing Data
The study included 479 active-duty men, excluding 3 receiving testosterone replacement therapy; weighted mean age was 29.9 years and mean BMI was 28.4.
The article reports prevalence estimates and screening considerations, not treatment recommendations or prescribing outcomes.
Clinical Best Practices
Test testosterone when compatible signs or symptoms are present, consistent with current clinical guidelines.
Confirm a low morning concentration with repeat testing.
Consider obesity, illness, and physical stress when interpreting testosterone results.
Do not equate a low screening measurement with a diagnosis of hypogonadism.
